Close



Dec 20, 2022 03:02PM
Aug 15, 2022 09:00AM
Aug 15, 2022 09:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 06:42AM
Aug 11, 2022 04:00AM
Jul 7, 2022 06:30PM Radius Health Publishes Investor Presentation Outlining Company’s Progress and Board Process Resulting in Agreement to be Acquired at Significant Premium
Jul 7, 2022 06:30PM
Jul 7, 2022 08:00AM
Jul 7, 2022 08:00AM
Jun 23, 2022 09:15AM
Jun 23, 2022 09:15AM
Jun 23, 2022 09:15AM
Jun 22, 2022 06:24PM Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
Jun 22, 2022 04:30PM
Jun 22, 2022 04:30PM
Jun 22, 2022 04:30PM
Jun 8, 2022 08:00AM
Jun 8, 2022 08:00AM
Jun 6, 2022 10:54AM
Jun 6, 2022 09:02AM Radius Health (RDUS) and Menarini Report Subgroup Analysis from the Elacestrant Ohase 3 EMERALD Trial
Jun 6, 2022 09:00AM
Jun 6, 2022 09:00AM
Jun 6, 2022 07:33AM
Jun 6, 2022 07:30AM
Jun 6, 2022 07:30AM
Jun 1, 2022 04:17PM
Jun 1, 2022 04:15PM Radius Health Update on Abaloparatide Transdermal System
Jun 1, 2022 04:15PM
May 23, 2022 03:52AM
May 20, 2022 09:01AM
May 20, 2022 09:00AM
May 20, 2022 09:00AM
May 20, 2022 05:48AM
May 20, 2022 03:57AM Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology
May 19, 2022 05:01PM
May 19, 2022 05:00PM
May 19, 2022 05:00PM
May 5, 2022 07:30AM
May 5, 2022 07:30AM
Apr 5, 2022 08:00AM
Apr 5, 2022 08:00AM Radius Provides Agenda for Today’s R&D Webcast
Mar 16, 2022 08:33AM
Mar 16, 2022 08:30AM
Mar 16, 2022 08:30AM
Mar 8, 2022 08:30AM
Mar 8, 2022 08:30AM
Mar 7, 2022 08:30AM
Mar 7, 2022 08:30AM Wells Fargo Equity Research to Host Fireside Chat with Radius CEO
Mar 3, 2022 04:05PM

251,365 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All